Biohaven Pharmaceutical Holding Company Ltd

(NYSE:BHVN)

Latest On Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Date/Time Type Description Signal Details
2023-05-12 21:12 ESTNewsBiohaven Non-GAAP EPS of -$0.98N/A
2023-03-24 07:34 ESTNewsBiohaven Non-GAAP EPS of -$1.27 beats by $0.01N/A
2023-03-22 08:38 ESTNewsBiohaven acquires rights to potential brain disorder drug BHV-8000 for $10M upfrontN/A
2023-03-10 05:36 ESTNewsBiohaven: Spun And Done - Time To ExitN/A
2023-02-21 22:11 ESTNewsBiohaven's spinal muscular atrophy therapy gets FDA fast track statusN/A
2023-01-04 17:02 ESTNewsBiohaven initiated at overweight at JP Morgan on neurological targetsN/A
2022-12-08 04:49 ESTNewsBiohaven Ltd: Assessing The SpinoffN/A
2022-11-09 21:19 ESTNewsBiohaven Non-GAAP EPS of -$1.25N/A
2022-10-21 04:41 ESTNewsBiohaven prices upsized 25M of stock offering at $10.50/shareN/A
2022-10-18 16:23 ESTNewsBiohaven stock falls 5% after the bell on 20M share offeringN/A
2022-10-07 13:52 ESTNewsBiotech in recovery; but Piper Sandler cites negative fund flowsN/A
2022-10-07 13:49 ESTNewsM&A may be a tailwind for biotech sector into end of year, analyst saysN/A
2022-10-07 13:40 ESTNews'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potentialN/A
2022-10-06 23:49 ESTNewsBiohaven Stub May Provide An Interesting Setup For InvestorsN/A
2022-09-29 23:19 ESTNewsBiohaven says ALS candidate failed in key trialN/A
2022-09-28 00:37 ESTNewsPfizer acquisition of Biohaven Pharmaceuticals expected to close Oct. 3N/A
2022-09-19 19:50 ESTNewsBiohaven announces timeline for spinoffN/A
2022-08-17 15:12 ESTNewsBiohaven: Non-Standard Merger Consideration Makes This A BuyN/A
2022-08-16 05:06 ESTNewsSoros Fund Management takes new stakes in GCP, Biohaven, TeslaN/A
2022-08-05 15:33 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6MN/A
2022-07-07 09:59 ESTNewsBiohaven begins enrolling in late-stage trial of spinal muscular atrophy therapyN/A
2022-06-15 23:08 ESTNewsBiohaven Deal: Pfizer Gives Away A FreerollN/A
2022-06-01 11:56 ESTNewsFederal Trade Commission to hold pharma merger and antitrust workshopN/A
2022-05-23 14:53 ESTNewsBiohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progressionN/A
2022-05-23 14:53 ESTNewsBiohaven gets FDA review for nasal spray zavegepant to treat migraineN/A
2022-05-11 01:00 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14MN/A
2022-05-11 01:00 ESTNewsPfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72%N/A
2022-05-06 21:00 ESTNewsBiohaven Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-27 19:21 ESTNewsPfizer, Biohaven's Vydura gets approval in EU to prevent/treat migraineN/A
2022-04-14 05:28 ESTNewsBiohaven Pharmaceutical: Recent Growth Will ContinueN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47MN/A
2022-02-26 00:18 ESTNewsBiohaven in licensing pact with Bristol Myers; to acquire Channel BiosciencesN/A
2022-02-26 00:18 ESTNewsPfizer, Biohaven's rimegepant gets EMA panel nod for migraine treatmentN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceutical Holding Company Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-26 00:17 ESTNewsBiohaven Pharmaceutical Holding's (BHVN) CEO Vlad Coric on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-25 05:15 ESTNewsBiohaven Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-22 19:32 ESTNewsBiohaven begins enrollment in phase 2/3 trial of Nurtec ODT in chronic rhinosinusitisN/A
2022-02-15 01:21 ESTNewsPfizer/ Biohaven announce late-stage migraine trial met main goals in Asia PacificN/A
2022-02-01 23:30 ESTNewsNew thematic psychedelic ETF hits the marketN/A
2022-01-28 21:24 ESTNewsAurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen newsN/A
2022-01-18 18:11 ESTNewsBiohaven’s Troriluzole to undergo glioblastoma trial designed to study multiple therapiesN/A
2022-01-14 05:01 ESTNewsAurinia Pharmaceuticals reverses decline after report on potential M&A interestN/A
2022-01-10 16:33 ESTNewsBiohaven forms research collaboration to advance TRPM3 antagonists for pain managementN/A
2022-01-06 09:41 ESTNewsBiohaven reports preliminary Q4 Nurtec ODT revenue of $190MN/A
2021-12-07 06:52 ESTNewsBiohaven names Vlad Coric as Chairman, appoints new CFON/A
2021-12-06 12:13 ESTNewsBiohaven says pivotal study for intranasal migraine therapy met main goalsN/A
2021-12-06 12:13 ESTNewsBiohaven names new CEO, CFON/A
2021-11-18 11:13 ESTNewsBiohaven, Artizan to work on Parkinson's drug discovery programN/A
2021-11-17 13:22 ESTNewsBiohaven's migraine med Nurtec approved in KuwaitN/A
2021-11-10 03:44 ESTNewsPfizer to gain ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B dealN/A

About Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

BHVN Quotes by TradingView

See Advanced Chart

General

  • Name Biohaven Pharmaceutical Holding Company Ltd
  • Symbol BHVN
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 825
  • Fiscal Year EndDecember
  • IPO Date2017-05-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biohavenpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 71.25
  • Price/Book (Most Recent Quarter) 31.82
  • Enterprise Value Revenue 73.75
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$10.49
  • Next Year EPS Estimate -$5.57
  • Next Quarter EPS Estimate -$2.73
  • Operating Margin -1014%
  • Return on Assets -78%
  • Revenue 63.63 million
  • Earnings Per Share -$9.14
  • Revenue Per Share $1.08
  • Gross Profit 45.93 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 4.42 billion
  • EBITDA -356321504
  • Analyst Target Price $102.09
  • Book Value Per Share $2.09
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 54.37 million
  • % Held by Insiders 1379%
  • % Held by Institutions 117.55%
  • Shares Short 5.76 million
  • Shares Short Prior Month 5.98 million
  • Short Ratio 11.39
  • Short % of Float 13%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.08
  • 52 Week High $100.77
  • 52 Week Low $28.26
  • 50 Day Moving Average 82.8
  • 200 Day Moving Average 80.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$2.69-$2.56-4.98%
2020-09-302020-11-09$17.66 million-$2.67-$2.866.58%
2020-06-302020-08-10$9.7 million-$2.55-$2.8410.27%
2020-03-312020-05-07$1.15 million-$2.39-$2.462.94%
2019-12-312020-02-25$N/A-$2.85-$1.91-49.31%
2019-09-302019-11-01$N/A-$2.04-$1.57-30.24%
2019-06-302019-08-08$N/A-$4.67-$2.09-123.21%
2019-03-312019-05-07$N/A-$1.41-$1.505.94%
2018-12-312019-02-28$N/A-$1.33-$1.21-10.12%
2018-09-302018-11-14$N/A-$1.53-$1.08-42.33%
2018-06-302018-08-14$N/A-$1.01-$1.053.68%
2018-03-312018-05-15$N/A-$2.32-$1.17-98.29%
2017-12-312018-03-06$N/A-$0.75-$1.3544.34%
2017-09-302017-11-14$N/A-$1.19-$1.243.78%
2017-06-302017-08-14$N/A-$1.78-$0.62-185.94%
2017-03-312017-06-16$N/A-$1.74-$1.45-20%

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Chart:

Biohaven Pharmaceutical Holding Company Ltd (BHVN) News:

Below you will find a list of latest news for Biohaven Pharmaceutical Holding Company Ltd (BHVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-1710CALL0 0677.39TRUE00
2026-04-172.59.69CALL0 36376.74TRUE00
2026-04-1740CALL0 094.78TRUE00
2026-04-1753.1CALL2 48149.22TRUE3.10
2026-04-1762.5CALL4 1105.17TRUE2.50
2026-04-177.51.95CALL0 313114.61TRUE00
2026-04-1790.65CALL27 1041103.26FALSE-0.29-0.31
2026-04-17100.32CALL192 321996.2FALSE-0.18-0.36
2026-04-17110.15CALL46 54993.29FALSE-0.1-0.4
2026-04-1712.50.08CALL9 1204103.41FALSE-0.02-0.2
2026-04-17140.31CALL0 287164.84FALSE00
2026-04-17150.05CALL45 2611124.93FALSE00
2026-04-17160.1CALL0 97154.69FALSE00
2026-04-1717.50.05CALL0 1055170.23FALSE00
2026-04-17191.19CALL0 17224.56FALSE00
2026-04-17200.05CALL0 243244.67FALSE00
2026-04-17210.65CALL0 16322.16FALSE00
2026-04-1722.50.29CALL0 781328.14FALSE00
2026-04-17250.05CALL0 137355.95FALSE00
2026-04-1727.50.05CALL0 143373.68FALSE00
2026-04-17300.06CALL0 124389.47FALSE00
2026-04-1732.50.55CALL0 172403.68FALSE00
2026-04-17350.4CALL0 1014416.6FALSE00
2026-04-1710PUT0 0475.33FALSE00
2026-04-172.50.25PUT0 16374.54FALSE00
2026-04-1740PUT0 0306.37FALSE00
2026-04-1750.08PUT0 142182.56FALSE00
2026-04-1760.27PUT0 8191.57FALSE00
2026-04-177.50.4PUT24 64395.14FALSE0.150.6
2026-04-1791.17PUT66 30694.95TRUE0.220.23
2026-04-17101.76PUT5 49073.86TRUE1.760
2026-04-17112.7PUT1 23684.89TRUE2.70
2026-04-1712.53.56PUT0 3230TRUE00
2026-04-17144.37PUT0 1660TRUE00
2026-04-17155.98PUT0 2460TRUE00
2026-04-17166PUT0 190TRUE00
2026-04-1717.58.45PUT0 270TRUE00
2026-04-17190PUT0 00TRUE00
2026-04-17208PUT0 2238.84TRUE00
2026-04-17210PUT0 00TRUE00
2026-04-1722.511.1PUT0 00TRUE00
2026-04-17250PUT0 0290.91TRUE00
2026-04-1727.516.4PUT0 00TRUE00
2026-04-173017.86PUT0 00TRUE00
2026-04-1732.518.8PUT0 00TRUE00
2026-04-173523.7PUT0 30TRUE00
2026-05-1510CALL0 0458.87TRUE00
2026-05-1520CALL0 0320TRUE00
2026-05-1530CALL0 0181.38TRUE00
2026-05-1540CALL0 0149.8TRUE00
2026-05-1550CALL0 0121.32TRUE00
2026-05-1560CALL0 0128.22TRUE00
2026-05-1570CALL0 0122.29TRUE00
2026-05-1580CALL0 0120.81TRUE00
2026-05-1591.06CALL11 5101.93FALSE-0.23-0.18
2026-05-15100.8CALL1 111105.78FALSE-0.25-0.24
2026-05-15110.47CALL45 3296.49FALSE-0.16-0.25
2026-05-15120.35CALL2 6799.75FALSE-0.07-0.17
2026-05-15130CALL0 097.69FALSE00
2026-05-15140CALL0 0144.65FALSE00
2026-05-15150.4CALL0 1174.42FALSE00
2026-05-15160.3CALL0 1148.72FALSE00
2026-05-15170CALL0 0178.82FALSE00
2026-05-15180CALL0 0192.05FALSE00
2026-05-1510PUT0 0778.66FALSE00
2026-05-1520PUT0 0459.93FALSE00
2026-05-1530PUT0 0333.59FALSE00
2026-05-1540PUT0 0254.36FALSE00
2026-05-1550PUT0 0195.96FALSE00
2026-05-1560PUT0 0118.25FALSE00
2026-05-1570PUT0 0105.23FALSE00
2026-05-1581PUT6 10098.17FALSE0.20.25
2026-05-1590PUT0 0101.77TRUE00
2026-05-15100PUT0 0106.67TRUE00
2026-05-15113PUT1 093.45TRUE30
2026-05-15120PUT0 0103.81TRUE00
2026-05-15130PUT0 092.57TRUE00
2026-05-15140PUT0 0110.42TRUE00
2026-05-15150PUT0 0112.88TRUE00
2026-05-15160PUT0 0142.76TRUE00
2026-05-15170PUT0 00TRUE00
2026-05-15180PUT0 00TRUE00
2026-07-1710CALL0 0281.27TRUE00
2026-07-172.50CALL0 0179.69TRUE00
2026-07-1746.99CALL0 30TRUE00
2026-07-1755.7CALL0 2137.88TRUE00
2026-07-1763.95CALL0 41127.51TRUE00
2026-07-177.53.6CALL0 22122.67TRUE00
2026-07-1792.72CALL0 20137.44FALSE00
2026-07-17101.5CALL6 202107.68FALSE1.50
2026-07-17111.5CALL0 3499.81FALSE00
2026-07-1712.51.05CALL5 1460113.4FALSE-0.15-0.13
2026-07-17140.8CALL5 116112.18FALSE0.80
2026-07-17150.9CALL0 568107.08FALSE00
2026-07-17161CALL0 57797.44FALSE00
2026-07-1717.50.42CALL1 184109.35FALSE0.420
2026-07-17191.9CALL0 48117.23FALSE00
2026-07-17200.3CALL1 102110.98FALSE0.30
2026-07-17210.64CALL0 274130.06FALSE00
2026-07-1710PUT0 0253.72FALSE00
2026-07-172.50PUT0 0172.23FALSE00
2026-07-1740PUT0 0153.99FALSE00
2026-07-1750.55PUT0 2120.61FALSE00
2026-07-1760PUT0 0118.5FALSE00
2026-07-177.51.35PUT11 97102.73FALSE1.350
2026-07-1792.05PUT0 77129.59TRUE00
2026-07-17102.82PUT0 127100.57TRUE00
2026-07-17113.17PUT0 129102.41TRUE00
2026-07-1712.55.3PUT0 29116.61TRUE00
2026-07-17144.6PUT0 4110.02TRUE00
2026-07-17156PUT0 160117.85TRUE00
2026-07-17165.2PUT0 100108.08TRUE00
2026-07-1717.50PUT0 0105.21TRUE00
2026-07-17199.2PUT0 50108.47TRUE00
2026-07-17209.2PUT0 4107.96TRUE00
2026-07-17219.8PUT0 498.05TRUE00
2026-10-1640CALL0 0183.83TRUE00
2026-10-1650CALL0 0173.46TRUE00
2026-10-1660CALL0 099.2TRUE00
2026-10-1670CALL0 0123.42TRUE00
2026-10-1683.4CALL0 5121.91TRUE00
2026-10-1690CALL0 0120.63FALSE00
2026-10-16100CALL0 0105.46FALSE00
2026-10-16113.87CALL0 1110.53FALSE00
2026-10-16120CALL0 0120.14FALSE00
2026-10-16130CALL0 0132.62FALSE00
2026-10-16140CALL0 0115.33FALSE00
2026-10-16152.2CALL0 25105.92FALSE00
2026-10-16160CALL0 0116.38FALSE00
2026-10-16170CALL0 0119.13FALSE00
2026-10-16181.22CALL2 1121.23FALSE1.220
2026-10-16190CALL0 0123.38FALSE00
2026-10-16200CALL0 6120.57FALSE00
2026-10-1640PUT0 0113.75FALSE00
2026-10-1650.6PUT0 1117.83FALSE00
2026-10-1661.32PUT0 1118.16FALSE00
2026-10-1671.5PUT0 1113.48FALSE00
2026-10-1680PUT0 099.07FALSE00
2026-10-1692.64PUT0 17112.38TRUE00
2026-10-16100PUT0 0108.37TRUE00
2026-10-16113.27PUT0 1594.94TRUE00
2026-10-16120PUT0 081.76TRUE00
2026-10-16130PUT0 0112.07TRUE00
2026-10-16140PUT0 0111.07TRUE00
2026-10-16150PUT0 0109.15TRUE00
2026-10-16160PUT0 0110.61TRUE00
2026-10-16178.05PUT0 2106.99TRUE00
2026-10-16180PUT0 0107.14TRUE00
2026-10-16190PUT0 0106.61TRUE00
2026-10-16200PUT0 0102.72TRUE00
2026-12-182.59CALL0 35134.78TRUE00
2026-12-1857.1CALL0 30163.46TRUE00
2026-12-1860CALL0 0157.57TRUE00
2026-12-187.55CALL0 78119.57TRUE00
2026-12-1890CALL0 0126.11FALSE00
2026-12-18103.6CALL0 256102.4FALSE00
2026-12-18110CALL0 0110.26FALSE00
2026-12-1812.53.3CALL0 127123.78FALSE00
2026-12-18153.3CALL0 584114.38FALSE00
2026-12-1817.52CALL0 79124.54FALSE00
2026-12-18201.8CALL0 677123.74FALSE00
2026-12-1822.52.41CALL0 12118.24FALSE00
2026-12-18251.53CALL0 237121.67FALSE00
2026-12-1827.50CALL0 0125.21FALSE00
2026-12-18300.79CALL0 5114.96FALSE00
2026-12-1832.51.5CALL0 1130.38FALSE00
2026-12-18351.45CALL0 54133.29FALSE00
2026-12-1837.50CALL0 0169.07FALSE00
2026-12-18400.8CALL0 4141.35FALSE00
2026-12-1842.51.25CALL0 1144.45FALSE00
2026-12-18451.9CALL0 37140.58FALSE00
2026-12-1847.50CALL0 2145.56FALSE00
2026-12-18501CALL0 11140.91FALSE00
2026-12-1852.52.75CALL0 9140.69FALSE00
2026-12-18553.33CALL0 2142.88FALSE00
2026-12-1857.50CALL0 0144.96FALSE00
2026-12-18601.05CALL0 15146.93FALSE00
2026-12-18650.15CALL0 38150.6FALSE00
2026-12-182.50.4PUT0 65121.62FALSE00
2026-12-1850.75PUT0 2108.37FALSE00
2026-12-1860PUT0 0129.4FALSE00
2026-12-187.52.08PUT0 164134.76FALSE00
2026-12-1890PUT0 0112.71TRUE00
2026-12-18102.47PUT0 27193.42TRUE00
2026-12-18110PUT0 086.19TRUE00
2026-12-1812.55PUT0 31885.68TRUE00
2026-12-18157.05PUT0 190108.28TRUE00
2026-12-1817.58.93PUT0 475.46TRUE00
2026-12-18209.8PUT0 100103.81TRUE00
2026-12-1822.50PUT0 22103.3TRUE00
2026-12-182516PUT0 8102.87TRUE00
2026-12-1827.50PUT0 0103.16TRUE00
2026-12-183022.56PUT0 3300TRUE00
2026-12-1832.50PUT0 00TRUE00
2026-12-18350PUT0 50TRUE00
2026-12-1837.50PUT0 00TRUE00
2026-12-184032.3PUT0 00TRUE00
2026-12-1842.50PUT0 00TRUE00
2026-12-18450PUT0 00TRUE00
2026-12-1847.50PUT0 00TRUE00
2026-12-18500PUT0 00TRUE00
2026-12-1852.50PUT0 00TRUE00
2026-12-18550PUT0 00TRUE00
2026-12-1857.50PUT0 00TRUE00
2026-12-18600PUT0 00TRUE00
2026-12-18650PUT0 00TRUE00
2027-01-152.57.4CALL0 56152.14TRUE00
2027-01-1557.5CALL0 75134.61TRUE00
2027-01-157.55CALL0 56134.47TRUE00
2027-01-15104.02CALL0 700103.23FALSE00
2027-01-1512.52.3CALL1 301110.86FALSE-0.25-0.1
2027-01-15152.22CALL2 4588121.74FALSE2.220
2027-01-1517.51.55CALL1 89109.93FALSE1.550
2027-01-15201.7CALL0 105140.21FALSE00
2027-01-1522.50CALL0 3139.97FALSE00
2027-01-15252.67CALL0 52140.31FALSE00
2027-01-1527.50.7CALL1 459104.74FALSE0.70
2027-01-15300.71CALL0 3978109.26FALSE00
2027-01-1532.51.42CALL0 8152.36FALSE00
2027-01-15351.56CALL0 5134.62FALSE00
2027-01-1537.50CALL0 0226.29FALSE00
2027-01-15400.8CALL0 106226.15FALSE00
2027-01-1542.51.46CALL0 50229.23FALSE00
2027-01-15452CALL0 8131.41FALSE00
2027-01-1547.50CALL0 0227.96FALSE00
2027-01-15500.8CALL0 11230.48FALSE00
2027-01-1552.50CALL0 0232.85FALSE00
2027-01-15551.4CALL0 1235.09FALSE00
2027-01-1557.50.05CALL0 1237.21FALSE00
2027-01-15602.05CALL0 6239.22FALSE00
2027-01-15650.74CALL0 11185.79FALSE00
2027-01-152.50.45PUT0 14122.86FALSE00
2027-01-1551.52PUT0 4107.75FALSE00
2027-01-157.52PUT0 24122.46FALSE00
2027-01-15103.82PUT0 308102.28TRUE00
2027-01-1512.55.5PUT0 4102.3TRUE00
2027-01-15157.3PUT0 230102.13TRUE00
2027-01-1517.59.48PUT0 1299.86TRUE00
2027-01-152010.7PUT0 11599.86TRUE00
2027-01-1522.514.9PUT0 397.2TRUE00
2027-01-15250PUT0 896.45TRUE00
2027-01-1527.50PUT0 099.65TRUE00
2027-01-15300PUT0 4101.85TRUE00
2027-01-1532.50PUT0 097.93TRUE00
2027-01-153522PUT0 20TRUE00
2027-01-1537.528.65PUT0 200TRUE00
2027-01-154030.09PUT0 00TRUE00
2027-01-1542.50PUT0 00TRUE00
2027-01-15450PUT0 00TRUE00
2027-01-1547.50PUT0 00TRUE00
2027-01-15500PUT0 00TRUE00
2027-01-1552.50PUT0 00TRUE00
2027-01-15550PUT0 00TRUE00
2027-01-1557.50PUT0 00TRUE00
2027-01-15600PUT0 00TRUE00
2027-01-15650PUT0 00TRUE00
2028-01-212.57.9CALL0 483141.3TRUE00
2028-01-2158.35CALL0 126124.07TRUE00
2028-01-217.54.1CALL10 48585.64TRUE-1.15-0.22
2028-01-21105CALL0 714106.49FALSE00
2028-01-2112.52.95CALL5 10486.63FALSE2.950
2028-01-21153CALL1 115096.82FALSE-0.95-0.24
2028-01-2117.56CALL0 1793.23FALSE00
2028-01-21205.6CALL0 9999.05FALSE00
2028-01-2122.52.7CALL0 6103.94FALSE00
2028-01-21252.32CALL0 57108.15FALSE00
2028-01-2127.54.96CALL0 28111.84FALSE00
2028-01-21302.05CALL0 929121.21FALSE00
2028-01-2132.50CALL0 0118.08FALSE00
2028-01-21352.75CALL0 132115.22FALSE00
2028-01-212.50.8PUT0 11124.73FALSE00
2028-01-2150PUT0 0139.24FALSE00
2028-01-217.52.95PUT0 8108.86FALSE00
2028-01-21105PUT10 77698.72TRUE50
2028-01-2112.56.75PUT0 2295.66TRUE00
2028-01-21157.72PUT0 1193.92TRUE00
2028-01-2117.512.42PUT0 199.37TRUE00
2028-01-212011.87PUT0 095.43TRUE00
2028-01-2122.50PUT0 089.98TRUE00
2028-01-21250PUT0 095.62TRUE00
2028-01-2127.50PUT0 091.53TRUE00
2028-01-21300PUT0 091.77TRUE00
2028-01-2132.50PUT0 095.97TRUE00
2028-01-213526PUT0 2489.29TRUE00

Latest BHVN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST40$143.84
Jun 13, 2022 7:59 PM EST9$143.84
Jun 13, 2022 7:59 PM EST8$143.87
Jun 13, 2022 7:59 PM EST100$143.87
Jun 13, 2022 7:59 PM EST3$143.83

Biohaven Pharmaceutical Holding Company Ltd (BHVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719006904/0000215457-19-006904-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719008296/0000215457-19-008296-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720008248/0000834237-20-008248-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720009073/0000834237-20-009073-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465918071968/0001104659-18-071968-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919015412/0001104659-19-015412-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919020231/0001104659-19-020231-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027408/0001104659-19-027408-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027610/0001104659-19-027610-index.htm
2019-08-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000110465919046550/0001104659-19-046550-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920003210/0001104659-20-003210-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920009364/0001104659-20-009364-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920027268/0001104659-20-027268-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920041258/0001104659-20-041258-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047706/0001104659-20-047706-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047741/0001104659-20-047741-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000114420419008285/0001144204-19-008285-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010164/0001209191-19-010164-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/0001209191-19-010166-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010174/0001209191-19-010174-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010177/0001209191-19-010177-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010184/0001209191-19-010184-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010209/0001209191-19-010209-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010214/0001209191-19-010214-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023434/0001209191-19-023434-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023435/0001209191-19-023435-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2019-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032463/0001209191-19-032463-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/0001209191-19-032465-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032466/0001209191-19-032466-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032468/0001209191-19-032468-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032470/0001209191-19-032470-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032472/0001209191-19-032472-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039783/0001209191-19-039783-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039785/0001209191-19-039785-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417319000086/0001274173-19-000086-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417320000063/0001274173-20-000063-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001022/0001410578-19-001022-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001524/0001410578-19-001524-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006297/0001562180-19-006297-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-01-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000722/0001562180-20-000722-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000723/0001562180-20-000723-index.htm
2020-03-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002440/0001562180-20-002440-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003254/0001562180-20-003254-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003255/0001562180-20-003255-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003256/0001562180-20-003256-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003257/0001562180-20-003257-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003258/0001562180-20-003258-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004469/0001562180-20-004469-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/0001562180-20-004470-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-123/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004473/0001562180-20-004473-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000002/0001562230-20-000002-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000003/0001562230-20-000003-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000161577419002508/0001615774-19-002508-index.htm
2018-12-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1689813/000162828018014980/0001628280-18-014980-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014982/0001628280-18-014982-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014985/0001628280-18-014985-index.htm
2018-12-12S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015071/0001628280-18-015071-index.htm
2018-12-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015109/0001628280-18-015109-index.htm
2019-06-17S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008046/0001628280-19-008046-index.htm
2019-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008061/0001628280-19-008061-index.htm
2019-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008196/0001628280-19-008196-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008232/0001628280-19-008232-index.htm
2020-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000632/0001628280-20-000632-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000742/0001628280-20-000742-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828020000788/0001628280-20-000788-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981318000042/0001689813-18-000042-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000047/0001689813-18-000047-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000049/0001689813-18-000049-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000010/0001689813-19-000010-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000014/0001689813-19-000014-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/0001689813-19-000020-index.htm
2019-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000022/0001689813-19-000022-index.htm
2019-05-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000026/0001689813-19-000026-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000030/0001689813-19-000030-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000034/0001689813-19-000034-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000044/0001689813-19-000044-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000046/0001689813-19-000046-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000052/0001689813-19-000052-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000055/0001689813-19-000055-index.htm
2019-08-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000056/0001689813-19-000056-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000066/0001689813-19-000066-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000088/0001689813-19-000088-index.htm
2019-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000089/0001689813-19-000089-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000106/0001689813-19-000106-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000107/0001689813-19-000107-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000108/0001689813-19-000108-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000109/0001689813-19-000109-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000110/0001689813-19-000110-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000111/0001689813-19-000111-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000112/0001689813-19-000112-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000113/0001689813-19-000113-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/0001689813-19-000130-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000014/0001689813-20-000014-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000016/0001689813-20-000016-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000022/0001689813-20-000022-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000027/0001689813-20-000027-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000030/0001689813-20-000030-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000040/0001689813-20-000040-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000042/0001689813-20-000042-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000044/0001689813-20-000044-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000046/0001689813-20-000046-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000049/0001689813-20-000049-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000053/0001689813-20-000053-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000057/0001689813-20-000057-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000063/0001689813-20-000063-index.htm
2018-12-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1689813/999999999518003115/9999999995-18-003115-index.htm

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Company Ltd (BHVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1379%
Institutional Ownership: 11755%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-15Elyse StockChief Medical OfficerSell800.0045.0136,008.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-18Elyse StockChief Medical OfficerSell17,700.0045.07797,749.620.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-02-04ERIC AGUIARDirectorSell17,609.0042.54749,086.860.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorSell10,000.0045.00450,000.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-11-20ERIC AGUIARDirectorSell6,729.0052.20351,234.290.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-22ERIC AGUIARDirectorSell1,250.0055.2469,050.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-09ERIC AGUIARDirectorSell4,072.0055.11224,410.770.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-16ERIC AGUIARDirectorSell3,537.0055.13194,984.550.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-01-10John TiltonChief Commercial OfficerSell10,500.0037.67395,535.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-12John TiltonChief Commercial OfficerSell10,000.0050.11501,100.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-02-21JULIA P GREGORYDirectorSell12,000.0043.56522,720.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorSell12,000.0054.75656,956.800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsSell3,935.0053.03208,665.180.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsSell21,065.0053.041,117,205.450.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-01-09ERIC AGUIARDirectorSell30,000.0056.391,691,700.000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2019-02-04ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-03-12John TiltonChief Commercial OfficerBuy10,000.009.2992,900.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-06-26JOHN W CHILDSDirectorBuy10,000.0040.37403,700.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-03-26Declan DooganDirectorSell5,824.0053.72312,865.281,014,827.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-22Declan DooganDirectorSell5,351.0053.66287,134.661,020,651.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-01Declan DooganDirectorSell50,000.0047.192,359,500.001,026,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-01-10John TiltonChief Commercial OfficerBuy10,500.009.2997,545.0010,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-22JOHN W CHILDSDirectorBuy107,500.009.29998,675.00107,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-03-01Declan DooganDirectorSell595.0045.4127,018.951,076,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-27Declan DooganDirectorSell23,384.0045.711,068,882.641,076,597.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Vlad CoricChief Executive OfficerBuy10,950.0010,950.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-02-25Declan DooganDirectorSell13,943.0045.49634,267.071,099,981.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-19Declan DooganDirectorSell1,400.0045.5163,714.001,113,924.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-15Declan DooganDirectorSell678.0045.4230,794.761,115,324.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-13Declan DooganDirectorSell6,158.0044.24272,429.921,116,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-12Declan DooganDirectorSell33,842.0044.321,499,877.441,122,160.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2018-12-03Declan DooganDirectorSell40,000.0041.951,678,000.001,156,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-02-21JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-18John TiltonCCO-Rare & Neurologic DisorderBuy1,250.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2020-01-08ERIC AGUIARDirectorBuy1,250.0055.9169,887.501,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-22ERIC AGUIARDirectorSell150.0058.868,828.601,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtBuy125,000.000.6176,250.00125,341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-12Elyse StockChief Medical OfficerSell15,925.0064.891,033,347.7713,234.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtBuy986.000.61601.461,327.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-11James EngelhartChief Financial OfficerSell4,847.0063.19306,286.2913,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell200.0058.0011,599.001,400.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy11,453.009.29106,398.3715,975.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell671.0056.9938,243.181,600.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell59,914.0075.254,508,822.081,741.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell1,300.0077.70101,005.061,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2019-02-04ERIC AGUIARDirectorBuy7,609.0020.79158,191.1117,609.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-10-18Elyse StockChief Medical OfficerBuy17,700.0010.82191,514.0017,700.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2020-06-11James EngelhartChief Financial OfficerSell5,972.0062.07370,697.5718,322.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-12Elyse StockChief Medical OfficerSell11,390.0065.80749,497.311,844.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-06-26Vlad CoricChief Executive OfficerBuy5,000.0040.22201,100.0019,130.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2020-01-22ERIC AGUIARDirectorBuy771.0032.4224,995.822,021.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsBuy21,065.000.6112,849.6521,065.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell5,261.0075.62397,843.6621,878.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy20,716.0020.79430,685.6422,560.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0055.9927,995.502,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-06-27Robert BermanChief Medical OfficerBuy2,500.0042.30105,750.00240,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2020-06-11James EngelhartChief Financial OfficerBuy19,772.009.29183,681.8824,294.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-04-07JOHN W CHILDSDirectorSell14,734.0033.26490,119.142,476,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-08-11JOHN W CHILDSDirectorBuy2,600.0060.32156,823.942,479,538.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-08-11JOHN W CHILDSDirectorBuy7,271.0061.28445,567.612,486,809.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-04-07JOHN W CHILDSDirectorSell93,268.0032.923,070,130.742,491,672.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2019-06-27James EngelhartChief Financial OfficerBuy2,500.0043.05107,625.002,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2020-08-11JOHN W CHILDSDirectorBuy15,129.0061.87936,093.262,501,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-11JOHN W CHILDSDirectorBuy6,678.0059.00393,983.972,508,616.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-21JOHN W CHILDSDirectorBuy3,322.0059.25196,828.502,511,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-23Gregory BaileyDirectorSell212.0079.9416,948.002,545,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-23Gregory BaileyDirectorSell10,191.0078.89803,918.052,545,870.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell3,100.0079.88247,632.032,556,061.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell21,466.0079.411,704,720.242,559,161.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-19Gregory BaileyDirectorSell4,554.0078.98359,655.342,580,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-03-25Gregory BaileyDirectorBuy107,500.009.29998,675.002,582,601.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2020-04-07JOHN W CHILDSDirectorSell10,908.0031.55344,196.492,584,940.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-10-16Gregory BaileyDirectorSell3,748.0078.88295,638.122,585,181.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-08-20Gregory BaileyDirectorBuy5,000.0037.65188,250.002,587,601.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2020-10-12Gregory BaileyDirectorSell6,729.0078.87530,740.452,588,929.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-07-08Gregory BaileyDirectorSell5,991.0075.93454,888.242,595,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-04-07JOHN W CHILDSDirectorSell81,090.0030.542,476,585.912,595,848.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-07-08Gregory BaileyDirectorSell44,009.0075.123,305,876.862,601,649.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-06-24Gregory BaileyDirectorSell2,395.0070.24168,224.802,645,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-24Gregory BaileyDirectorSell1,600.0069.29110,864.962,648,053.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell835.0075.1862,779.312,649,653.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell63,257.0074.604,719,256.862,650,488.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-04-06JOHN W CHILDSDirectorSell5,341.0031.76169,626.962,676,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-04-06JOHN W CHILDSDirectorSell144,659.0031.234,517,309.992,682,279.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-06-23Gregory BaileyDirectorSell24,084.0073.721,775,368.922,713,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsBuy23,500.009.29218,315.0027,139.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-23Gregory BaileyDirectorSell13,467.0072.70979,026.662,737,829.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-22Gregory BaileyDirectorSell49,132.0073.643,618,011.702,751,296.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy24,000.005.60134,400.0027,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0054.9727,485.852,771.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-05Gregory BaileyDirectorBuy212,500.000.61129,625.002,800,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-22Gregory BaileyDirectorSell20,659.0072.911,506,202.242,800,428.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-22Gregory BaileyDirectorSell10,540.0072.01758,961.162,821,087.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell428.0075.2232,193.392,831,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell22,584.0073.781,666,267.852,832,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell12,157.0072.93886,618.522,854,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell21,798.0071.981,568,935.032,866,796.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell58,238.0070.914,129,854.592,888,594.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-12Elyse StockChief Medical OfficerSell5,300.0064.05339,448.0429,159.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Gregory BaileyDirectorSell26,814.0070.101,879,792.792,946,832.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy150,000.005.60840,000.002,950,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-10James EngelhartChief Financial OfficerSell28,821.0066.661,921,135.8129,654.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-19Gregory BaileyDirectorSell22,012.0069.011,519,094.352,973,646.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy37,700.009.29350,233.002,987,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2019-12-18WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy3,000.003,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2020-01-09ERIC AGUIARDirectorBuy30,000.009.29278,700.0030,000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-06-05Gregory BaileyDirectorBuy20,000.0010.82216,400.003,007,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-05Gregory BaileyDirectorBuy18,000.0028.76517,680.003,025,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy1,000.0037.5437,540.003,049.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell4,010.0077.01308,799.273,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell55,626.0075.254,185,745.253,119.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-10John TiltonChief Commercial OfficerSell21,364.0066.701,425,036.4831,406.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy30,000.0050.721,521,600.0031,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-10John TiltonChief Commercial OfficerSell5,331.0068.57365,528.013,237.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-01-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.003,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy17,500.000.6110,675.0033,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Elyse StockChief Medical OfficerBuy3,375.003,375.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell300.0055.9716,791.00341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell1,400.0076.05106,467.48341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtSell986.0075.0774,015.96341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtSell4,296.0075.05322,431.12341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell2,778.0075.29209,144.51341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-12Elyse StockChief Medical OfficerSell4,351.0063.02274,208.7234,459.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-12-16ERIC AGUIARDirectorBuy3,537.0020.7973,534.233,537.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy590.0020.7912,266.103,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsSell600.0070.0542,027.483,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsSell24,000.0070.201,684,869.603,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell2,458.0077.42190,300.083,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy36,314.000.6122,151.5436,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-02-27Declan DooganDirectorSell1,900.0045.8687,134.00373,913.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Kimberly GentileSVP, Clinical OperationsBuy3,750.003,750.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-02-27Declan DooganDirectorSell18,270.0045.25826,717.50375,813.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy16,250.0032.42526,825.0038,810.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsBuy3,935.000.612,400.353,935.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-02-27Declan DooganDirectorSell6,875.0044.17303,668.75394,083.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-26Declan DooganDirectorSell100.0044.814,481.00400,958.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-26Declan DooganDirectorSell20,796.0044.31921,470.76401,058.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy400.005.602,240.004,039.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2019-12-09ERIC AGUIARDirectorBuy4,072.0020.7984,656.884,072.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell53,762.0053.432,872,449.904,129.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-02-25Declan DooganDirectorSell100.0045.744,574.00421,854.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-25Declan DooganDirectorSell20,334.0045.25920,113.50421,954.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsBuy600.005.603,360.004,239.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell15,783.0050.03789,623.49440,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell16,050.0044.97721,768.50442,288.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-10James EngelhartChief Financial OfficerSell300.0068.0720,420.014,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-11James EngelhartChief Financial OfficerSell2,452.0064.85159,015.394,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell8,262.0050.02413,265.24455,783.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell5,575.0044.11245,913.25458,338.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtBuy4,296.000.612,620.564,637.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell25,955.0050.151,301,643.25464,045.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell16,110.0050.02805,822.20475,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10James EngelhartChief Financial OfficerSell24,832.0067.531,676,989.394,822.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell7,883.0050.02394,307.66491,110.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell26,007.0050.151,304,251.05498,993.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10John TiltonChief Commercial OfficerBuy52,000.009.29483,080.0052,770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell67,450.0052.953,571,349.3557,891.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy25,000.005.60140,000.0058,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtBuy58,404.000.6135,626.4458,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell15,781.0076.421,205,938.266,097.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy25,000.005.60140,000.0061,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-12-18James EngelhartChief Financial OfficerBuy3,700.006,200.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-18Robert BermanSpecial Projects & Med OvrsghtBuy625.00625.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-06-16Declan DooganDirectorSell300.0069.4220,825.01626,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-16Declan DooganDirectorSell25,208.0068.731,732,457.61626,302.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell3,488.0054.89191,462.25641.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-16Declan DooganDirectorSell31,920.0067.902,167,514.83651,510.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-11-20ERIC AGUIARDirectorBuy6,729.0032.42218,154.186,729.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2020-06-16Declan DooganDirectorSell2,572.0066.94172,161.71683,430.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell15,797.0068.101,075,800.98686,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-11James EngelhartChief Financial OfficerSell6,501.0064.31418,057.866,974.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Charles ConwayChief Scientific OfficerBuy3,000.007,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2020-06-15Declan DooganDirectorSell18,703.0067.511,262,557.24701,799.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell24,690.0076.021,876,872.087,065.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-15Declan DooganDirectorSell34,336.0066.052,267,872.20720,502.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell11,164.0065.62732,560.47754,838.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-12Declan DooganDirectorSell25,914.0065.781,704,749.90766,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell2,467.0069.40171,201.91770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-12Declan DooganDirectorSell28,086.0064.791,819,683.51791,916.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-10-15Elyse StockChief Medical OfficerBuy800.0010.828,656.00800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2020-06-12Declan DooganDirectorSell18,400.0063.901,175,767.36820,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-12Declan DooganDirectorSell7,600.0062.93478,252.04838,402.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell25,039.0064.571,616,873.39846,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell22,838.0067.531,542,234.158,568.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-11Declan DooganDirectorSell18,474.0063.791,178,530.36871,041.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell20,043.0062.781,258,207.34889,515.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell16,444.0061.971,018,988.64909,558.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-04-16Declan DooganDirectorSell50,000.0061.923,096,000.00926,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2020-01-08Elyse StockChief Medical OfficerBuy937.0055.9152,387.67937.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2019-04-12Declan DooganDirectorSell38,825.0053.922,093,444.00976,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm